Category: Nexis Newswire

LONDON, 12 August 2026 – LexisNexis® Legal & Professional, a global leader in information, analytics and AI-powered legal workflow solutions, today announced it has acquired Globe Law and Business, a small, well-regarded UK-based publisher of specialist legal information. The acquisition adds specialist, practitioner-authored titles to the LexisNexis authoritative legal content library, which powers LexisNexis legal AI solutions, including Lexis+^® with Protégé.

Founded in 2005 and based in London, Globe Law and Business publishes 300 specialist titles written by practitioners from top commercial law firms, senior academics and in-house counsel. Its portfolio covers energy, banking and finance, insolvency, arbitration, intellectual property, private client and law firm management practice areas. Founder and Managing Director Sian O’Neill remains with the business following the acquisition.

LexisNexis Legal & Professional maintains one of the world’s most comprehensive repositories of trusted, verifiable legal content, with more than 200 billion documents and records, and four million new documents added daily. This essential, unique and constantly updated legal content is enriched, linked and structured to ground the company’s leading legal AI solutions. In Lexis+ with Protégé, this authoritative content powers agentic AI legal skills and workflow capabilities that help legal professionals draft, analyse, research and complete legal work with greater speed, accuracy and confidence.

Financial terms were not disclosed.

For more information on Lexis+ with Protégé, visit www.lexisnexis.com/ai.

About LexisNexis^® Legal & Professional
LexisNexis^® Legal & Professional provides AI-powered legal, regulatory, business information, analytics, and workflows that help customers increase their productivity, improve decision-making, achieve better outcomes, and advance the rule of law around the world. As a digital pioneer, the company was the first to bring legal and business information online with its Lexis^® and Nexis^® services. LexisNexis Legal & Professional, which serves customers in more than 150 countries with 11,900 employees worldwide, is part of RELX, a global provider of information-based analytics and decision tools for professional and business customers.

New York, NY – August 11, 2026 – Following a challenge brought by Mueller Sports Medicine, Inc., BBB National Programs’ National Advertising Division found certain claims made by Howies Hockey, Inc. to be puffery, but recommended superiority claims regarding its athletic and hockey tape products be modified or discontinued.

Mueller and Howies compete in the athletic sports tape market. Mueller challenged express and implied claims made by Howies for its Athletic Tape and Hockey Tape, specifically Howies’ use of the claim “World’s Highest Quality.”

The National Advertising Division (NAD) reviewed product packaging and point-of-sale displays where Howies Hockey’s claim “World’s Highest Quality” appears alone, without reference to specific product attributes or competitors. In this context, NAD found that the claim is puffery because the claim is an expression of corporate pride.

NAD also evaluated Howies’ webpages, social media, print advertising, and third-party retail sites where the claim “World’s Highest Quality” appears alongside descriptions of specific product attributes. NAD found that when the claims appear in conjunction with product attributes, it becomes an objective representation regarding the product’s performance for which substantiation is required.

NAD recommended that Howies discontinue the claim when it appears in close proximity to measurable product attributes or modify the advertising to avoid conveying the unsupported message that Howies products are superior.

Similarly, NAD also recommended that Howies make bona fide, good-faith efforts to have the superiority claim modified or discontinued on third-party retail websites.

In its advertiser statement, Howies Hockey stated that it “agrees to comply with the NAD’s recommendation.”

All BBB National Programs case decision summaries can be found in the case decision library. For the full text of NAD, NARB, and CARU decisions, subscribe to the online archive. Per NAD/NARB Procedures, this release may not be used for promotional purposes.

About BBB National Programs: BBB National Programs, a non-profit organization, is the home of U.S. independent industry self-regulation, currently operating more than 20 globally recognized programs that have been helping enhance consumer trust in business for more than 50 years. These programs provide third-party accountability and dispute resolution services that address existing and emerging industry issues, create fair competition for businesses, and a better experience for consumers. BBB National Programs continues to evolve its work and grow its impact by providing business guidance and fostering best practices in advertising, child-and-teen-directed marketing, data privacy, dispute resolution, automobile warranty, technology, and emerging areas. To learn more, visit bbbprograms.org.

About the National Advertising Division: The National Advertising Division (NAD) of BBB National Programs provides independent self-regulation and dispute resolution services, guiding the truthfulness of advertising across the U.S. NAD reviews national advertising in all media and its decisions set consistent standards for advertising truth and accuracy, delivering meaningful protection to consumers and creating fair competition for business.

New York, NY – August 5, 2026 – Following a challenge brought by Galderma Laboratories, L.P., BBB National Programs’ National Advertising Division found certain challenged claims made by Sanofi S.A. supported but recommended that Sanofi modify or discontinue other claims regarding long-lasting clearer skin, fast itch relief, and a prescriber-facing day-2 itch relief claim.

Galderma and Sanofi are multinational pharmaceutical companies that each market FDA-approved biologic treatments for moderate-to-severe eczema. Galderma challenged claims about DUPIXENT’s mechanism of action, ability to address inflammation and heal skin from within, efficacy, and claims that it works proactively to keep patients ahead of eczema.

The National Advertising Division (NAD) found claims that DUPIXENT helps patients “stay ahead of eczema,” blocks “a key source of inflammation,” can “help heal your skin from within,” and that many adults saw 90% clearer skin supported. NAD also determined that the challenged advertising did not convey the implied messages alleged by Galderma that DUPIXENT prevents eczema progression, blocks the most important source of inflammation, treats nerve inflammation, or promises complete healing of eczema-related skin lesions.

Although NAD found that the 90% clearer skin claim does not need a disclosure, NAD recommended that, to the extent Sanofi continues to present the results from one particular study as the basis for the claim in a disclosure, it use a disclosure that does not overstate the supporting evidence or obscure the treatment context. NAD also separately determined that an animated consumer-facing mechanism-of-action video likely conveyed the unsupported message that inhibition of IL-4 and IL-13 signaling alone is sufficient to address eczema.

NAD determined that Sanofi’s evidence supports a properly qualified claim that some adults achieved long-lasting clearer skin at four months and at one year and that some saw fast itch relief after the first dose at two weeks. However, NAD recommended modifying or discontinuing the challenged television claims to clearly and conspicuously disclose how many patients achieved the advertised results or that the results reflected treatment with DUPIXENT used in combination with topical corticosteroids.

NAD also reviewed a prescriber-facing claim that DUPIXENT reduced itch “starting as early as day 2,” and found that the post hoc analysis relied on by Sanofi did not support the message that Dupixent demonstrated a meaningful treatment benefit beginning as early as day 2 and recommended that Sanofi discontinue or modify the claim.

NAD also concluded that the advertising did not convey the challenged message that DUPIXENT is superior to all other FDA-approved eczema treatments.

In its advertiser statement, Sanofi stated that it “will comply with NAD’s recommendations.”

All BBB National Programs case decision summaries can be found in the case decision library. For the full text of NAD, NARB, and CARU decisions, subscribe to the online archive. Per NAD/NARB Procedures, this release may not be used for promotional purposes.

About BBB National Programs: BBB National Programs, a non-profit organization, is the home of U.S. independent industry self-regulation, currently operating more than 20 globally recognized programs that have been helping enhance consumer trust in business for more than 50 years. These programs provide third-party accountability and dispute resolution services that address existing and emerging industry issues, create fair competition for businesses, and a better experience for consumers. BBB National Programs continues to evolve its work and grow its impact by providing business guidance and fostering best practices in advertising, child-and-teen-directed marketing, data privacy, dispute resolution, automobile warranty, technology, and emerging areas. To learn more, visit bbbprograms.org.

About the National Advertising Division: The National Advertising Division (NAD) of BBB National Programs provides independent self-regulation and dispute resolution services, guiding the truthfulness of advertising across the U.S. NAD reviews national advertising in all media and its decisions set consistent standards for advertising truth and accuracy, delivering meaningful protection to consumers and creating fair competition for business.

New analysis also finds broad-based growth beyond high-volume plaintiffs, record design patent filings, continued concentration in the Eastern District of Texas, and more than $2.3 billion in 2025 patent damages

San Jose, CA, August 5, 2026 — LexisNexis^® Legal & Professional announced today the release of the Lex Machina^® 2026 Patent Litigation Report, a comprehensive, data-driven analysis of trends shaping U.S. patent litigation in federal district and appellate courts and before the Patent Trial and Appeal Board (PTAB). Powered by insights from Lex Machina^®, the LexisNexis^® Legal Analytics^® platform, the report examines key developments from 2023 through 2025, places those findings in historical context dating back to 2016, and includes current observations from the first half of 2026. The analysis encompasses 38,893 patent cases filed in U.S. district courts and 3,589 federal circuit court cases docketed from 2016 through 2025, together with PTAB petitions and appeals.

Key findings from the report include: 

• District court patent filings reach a ten-year high before pulling back in 2026: Plaintiffs filed 4,547 patent cases in 2025, a 19.6 percent increase over 2024 and the highest total in the 2016–2025 period. From January 1 through June 30, 2026, claimants filed approximately 1,900 new patent lawsuits, putting 2026 on pace to finish comfortably below the record level reached in 2025. 

• Patent damages remain above $2 billion for a fourth consecutive year: Courts awarded $2.353 billion in patent damages across 63 cases in 2025, excluding fees and interest. From 2023 through 2025, reasonable royalty awards totaled $8.156 billion, with $8.066 billion awarded through verdicts, underscoring the continuing role of juries in the highest-value patent recoveries. 
• PTAB activity enters a sharp slowdown: Inter partes review petitions fell approximately 8 percent to 1,208 in 2025, while post-grant review petitions increased to 75, their highest level since 2021. In the first half of 2026, parties filed only 201 PTAB petitions—fewer than in any other half-year period in at least a decade.

“Patent litigation strategy depends not only on understanding the law, but also on knowing how cases are actually progressing through the courts and PTAB,” said Michael J. Flynn, Partner at Morris, Nichols, Arsht & Tunnell LLP. “The Lex Machina Patent Litigation Report provides practical benchmarks on filings, venues, timing, outcomes, and damages that help us identify meaningful shifts and inform our clients’ litigation strategies.”

“The 2026 Patent Litigation Report captures a litigation landscape in transition,” said Eric Wright, senior vice president for Lex Machina at LexisNexis. “District court filings reached a ten-year high in 2025, with growth extending well beyond high-volume plaintiffs, while the first half of 2026 brought a pronounced slowdown—especially at the PTAB. In an environment this dynamic, legal teams need clear benchmarks on venue, timing, parties, counsel, outcomes, and damages. Lex Machina gives practitioners the data-backed intelligence to assess risk earlier, allocate resources more effectively, and make more confident litigation and business-development decisions.”

To request a copy of the report, visit LexisNexis.com/LexMachina.

The Lex Machina platform equips litigation professionals to develop stronger case strategies and generate business. From precise timing metrics that inform legal budgeting to trend data on top law firms and leading judges, Lex Machina supplements traditional legal research and experience with customized, data-backed insights. These insights help lawyers identify and pursue new matters, navigate motion and trial strategies, and negotiate smarter settlements, ultimately giving firms a competitive edge in litigation.

About LexisNexis^® Legal & Professional 

LexisNexis^® Legal & Professional provides AI-powered legal, regulatory, business information, analytics and workflows that help customers increase their productivity, improve decision-making, achieve better outcomes, and advance the rule of law around the world. As a digital pioneer, the company was the first to bring legal and business information online with its Lexis^® and Nexis^® services. LexisNexis Legal & Professional, which serves customers in more than 150 countries with 11,900 employees worldwide, is part of RELX, a global provider of information-based analytics and decision tools for professional and business customers.

About Lex Machina 

Lex Machina^® fundamentally changes how companies and law firms compete in the business and practice of law. The company provides strategic insights on judges, lawyers, law firms, parties, and other critical information across 22 federal practice areas and a rapidly growing number of state courts. Lex Machina allows law firms and companies to anticipate the behaviors and outcomes that different legal strategies will produce, supporting more effective case strategy and business development efforts.

Lex Machina was named Winner of the “Overall LegalTech Data Solution Provider of the Year” LegalTech Breakthrough Award 2025, “Best Data Analytics & Insight Solution” 2025 CODiE Award, and Winner of the “Media Excellence Award” for Analytics/Big Data 2024. Based in Silicon Valley, Lex Machina is part of LexisNexis^®, a leading global provider of legal, regulatory, and business information and analytics. For more information, please visit https://www.lexisnexis.com/en-us/products/lex-machina.page.

Michael J. Flynn is a customer of Lex Machina.

Media Contact

Venture PR lexmachina@venturepr.co 

Legal professionals, LexisNexis engineers, and AI collaborators like OpenAI and Amazon Web Services build side by side, solving workflow pain points with prototypes in hours and trusted products in weeks

NEW YORK, August 4, 2026 – LexisNexis^® Legal & Professional today announced the opening of its Customer Innovation Lab in New York City, a new model for how legal AI gets built and shipped. The Lab brings legal professionals, LexisNexis engineers, and AI technology collaborators together from the first working session to build as one team. Solutions to real legal challenges and novel ways to accomplish legal work become tested prototypes in hours or days and production-ready capabilities within weeks.

Here’s how the Lab works: Legal professionals from law firms, corporate legal departments, the judiciary, and academia bring specific pain points and new ideas on legal practice into the Lab. LexisNexis engineers build against them in real time. Prototypes are designed and tested that same day against the problems they were built to solve, then advance only if they clear LexisNexis’s standards for quality, accuracy, and security. Successful prototypes advance into new ways of working and new skills or agents within the LexisNexis agentic platform, either customized for the customer or scaled across the core LexisNexis platform.

Watch Greg Dickason, LexisNexis Chief Technology Officer, explain this new model: https://youtu.be/H6hAHEn1-Yo.

Already shipping from the Lab: The Lab has already turned ideation with dozens of customers into working prototypes and designs that have advanced into Lexis+^® with Protégé capabilities coming soon, including:

• LexisNexis-developed legal AI models. The Lab is advancing LexisNexis-developed models purpose-built for legal work, using authoritative legal content and deep legal expertise to improve performance, efficiency, and accuracy across complex legal tasks.
• An advanced, customer-managed Protégé Vault for analyzing complex multimedia materials. Legal professionals will be able to securely store and analyze documents, videos, images, audio files, and other matter materials. A lawyer could, for example, analyze a two-hour deposition in minutes with Protégé, pinpoint the exact moments when key facts emerge, and trace findings directly to the timestamps and source materials.
• Secure Protégé Workrooms for collaboration across teams. Legal professionals will be able to bring together and share documents, analyses, skills, and AI-assisted work related to a given matter with internal teams, outside counsel, clients, experts, and authorized participants, with precise permissions and access controls, all within the same secure LexisNexis environment.

What the Lab is solving now: The Lab is addressing legal drafting quality as a top priority in legal work. Independent research shows lawyers spend 40 to 60 percent of their time drafting and reviewing documents and contracts, more than on any other legal task. LexisNexis has confirmed this pattern directly with customers who identify the complex nature of legal drafting – including personalization, tonality, subject matter expertise, strategic positioning, and legal accuracy – as an unmet need.

The Lab is building, prototyping, and testing AI and agentic drafting capabilities that:

• Adapt to a firm’s or organization’s drafting style, precedents, and playbooks
• Flag risk and suggest redlines against a customer’s own standards
• Carry context across related documents, enabling legal professionals to draft a primary document and supporting materials without starting from scratch
• Provide document-aware editing tools tailored to the type of legal document being created
• Preserve lawyer control through visible AI-generated edits, Track Changes, and version history
• Surface LexisNexis proprietary trust markers at the point of need, helping users verify their work without the need for multi-step or cut-and-paste accuracy checks
• Integrate essential LexisNexis legal and predictive analytics including litigation, judicial, and regulatory analytics to inform more strategic and higher-quality drafting

AI technology collaborators, including OpenAI and Amazon Web Services, participate alongside customers and LexisNexis teams to explore how the latest model capabilities can be applied to complex legal work. LexisNexis engineers anchor every Lab session, applying LexisNexis’s secure infrastructure, authoritative content, and validation standards to evaluate every model output.

“Congratulations to LexisNexis on the opening of its Customer Innovation Lab. This new space reflects a shared belief that the most meaningful AI innovation happens through close collaboration with customers. We are thrilled to support LexisNexis as it turns that collaboration into new products and experiences with real-world impact.” — OpenAI

“Congratulations to LexisNexis on the launch of its Customer Innovation Lab,” said Scott Liska, VP AWSI, Amazon Web Services. “Bringing trusted AI into professional work requires both rapid innovation and a strong technology foundation. We look forward to continuing our collaboration with LexisNexis as it advances secure, authoritative AI capabilities for legal professionals.”

“Our vision is to empower customers with world-leading, purpose-built, and trusted legal AI,” said Greg Dickason, Chief Technology Officer, LexisNexis Legal & Professional. “The Customer Innovation Lab changes who’s in the room when legal AI gets built. Customers help originate and shape what we build from day one. Our job is to validate it, ground it in citable legal authority, and decide what’s ready to scale into Lexis+ with Protégé, the platform our customers rely on every day.”

The Customer Innovation Lab launches in New York City as an ongoing operation, with plans to expand globally. Interested law firms and legal departments can learn more at www.lexisnexis.com/lab.

About the LexisNexis Customer Innovation Lab

The LexisNexis Customer Innovation Lab brings legal professionals, LexisNexis engineers, and AI collaborators together to build legal AI solutions in real time. Rather than validating AI capabilities after they’re built, customers help originate and shape them from the first working session, turning their most complex legal work challenges into tested prototype solutions in hours or days, and trusted product-ready capabilities within weeks. Every capability advanced from the Lab is developed within LexisNexis’s private, secure, enterprise-grade infrastructure and must meet LexisNexis’s standards for quality, accuracy, and legal-domain performance before reaching customers. Capabilities are grounded in LexisNexis’s foundation of authoritative legal content that includes 200 billion documents and records with four million additions daily, 150 years of attorney-led curation, and Shepard’s^® citation intelligence.

About LexisNexis^® Legal & Professional

LexisNexis^® Legal & Professional provides AI-powered legal, regulatory, business information, analytics, and workflows that help customers increase their productivity, improve decision-making, achieve better outcomes, and advance the rule of law around the world. As a digital pioneer, the company was the first to bring legal and business information online with its Lexis^® and Nexis^® services. LexisNexis Legal & Professional, which serves customers in more than 150 countries with 11,900 employees worldwide, is part of RELX, a global provider of information-based analytics and decision tools for professional and business customers.

Enhancing tax advisory services with advanced research and authoritative insights

July 30, 2026, New York – LexisNexis^® Legal & Professional, a global leader in information, analytics, and AI-powered workflow solutions, and Neil Jesani Tax Advisors, a national full-service tax advisory firm, announced plans to collaborate on Tolley+ with Protégé to advance tax advisory services for CPA firms.

LexisNexis will support Neil Jesani Tax Advisors with access to authoritative tax content and AI-powered research tools, enabling the firm to navigate complex tax issues more efficiently and serve clients with greater confidence.

Tolley+ with Protégé was released in February 2026 as a reimagined version of the well-known Lexis Tax product that now includes AI capabilities that accelerate work and reduce manual review time while surfacing deeper insights from authoritative sources. By leveraging these comprehensive research tools, expert guidance, and up-to-date legislation, the firm aims to deepen their technical capability, improve efficiency, and provide greater confidence in client decision-making.

“Working with LexisNexis supports our commitment to delivering high-quality, technically robust advice,” said Neil Jesani, CEO & Founder, Neil Jesani Tax Advisors. “With access to Tolley+, we are well positioned to provide enhanced insight and practical solutions for our high-net worth clients and mid-market business partners.”

“Tax professionals are facing increasing complexity and growing demands for timely, accurate guidance,” said Paul Speca, Senior Vice President, U.S. Legal Markets, LexisNexis Legal & Professional. “We are pleased to support Neil Jesani Tax Advisors with Tolley+ with Protégé, combining authoritative tax intelligence and AI-powered research capabilities to help professionals work more efficiently, make informed decisions, and deliver greater value to their clients.”

This collaboration reflects a shared focus on quality, innovation, and delivering exceptional client outcomes.

To learn more about Tolley+ with Protege: Tolley+ | Solutions for Tax and Accounting Professionals

About Neil Jesani Tax Advisors

Founded in 2007, Neil Jesani Tax Advisors is a strategic tax advisory firm providing tailored solutions to individuals and businesses. The firm is known for its technical expertise, client-focused approach, and commitment to delivering practical and effective tax strategies.

About LexisNexis^® Legal & Professional

LexisNexis^® Legal & Professional provides AI-powered legal, regulatory, business information, analytics, and workflows that help customers increase their productivity, improve decision-making, achieve better outcomes, and advance the rule of law around the world. As a digital pioneer, the company was the first to bring legal and business information online with its Lexis^® and Nexis^® services. LexisNexis Legal & Professional, which serves customers in more than 150 countries with 11,900 employees worldwide, is part of RELX, a global provider of information-based analytics and decision tools for professional and business customers.

New York, NY – July 24, 2026 – In a BBB National Programs’ National Advertising Division challenge brought by Novo Nordisk Inc., Willow Health Services Inc. voluntarily discontinued certain advertising claims for its compounded semaglutide products.

The inquiry focused on express and implied claims made by Willow Health Services about the benefits, efficacy, and safety of its compounded semaglutide products. The challenged claims included statements that Willow’s products were proven to support weight loss, provided results comparable to FDA-approved semaglutide products, and offered effective weight loss outcomes without diet or exercise.

The National Advertising Division (NAD) initially referred this matter to the Federal Trade Commission (FTC), relevant state Attorneys General, and to the platforms on which the advertising appeared, as Willow failed to provide an advertiser statement indicating whether it would comply with NAD’s recommendations. Willow returned to NAD after discussion with the FTC, and NAD reopened the matter.

During the reopened inquiry, Willow informed NAD that it had permanently discontinued all the challenged claims. NAD will treat the discontinued claims, for compliance purposes, as though NAD recommended they be discontinued.

All BBB National Programs case decision summaries can be found in the case decision library. For the full text of NAD, NARB, and CARU decisions, subscribe to the online archive. This press release shall not be used for advertising or promotional purposes.

About BBB National Programs: BBB National Programs, a non-profit organization, is the home of U.S. independent industry self-regulation, currently operating more than a dozen globally recognized programs that have been helping enhance consumer trust in business for more than 50 years. These programs provide third-party accountability and dispute resolution services that address existing and emerging industry issues, create a fairer playing field for businesses, and a better experience for consumers. BBB National Programs continues to evolve its work and grow its impact by providing business guidance and fostering best practices in arenas such as advertising, child-and-teen-directed marketing, data privacy, dispute resolution, automobile warranty, technology, and emerging areas. To learn more, visit bbbprograms.org.

About the National Advertising Division: The National Advertising Division of BBB National Programs provides independent self-regulation and dispute resolution services, guiding the truthfulness of advertising across the U.S. The National Advertising Division reviews national advertising in all media and its decisions set consistent standards for advertising truth and accuracy, delivering meaningful protection to consumers and leveling the playing field for business.

New York, NY – July 21, 2026 – In a Fast-Track Swift challenge brought by Human Power of N Company (Humann), BBB National Programs’ National Advertising Division found that Force Factor Brands LLC substantiated its claims that Total Beets® is “America’s #1 Best-Selling Beets Brand,” the “#1 Best Selling Beets Brand in America,” and the “#1 Beets Brand in America” based on unit sales data. However, the National Advertising Division (NAD) recommended that Force Factor modify the claim “#1 Beets Brand in America” to disclose that the ranking is based on total unit sales.

Fast-Track SWIFT is an expedited process designed for single-issue advertising cases before NAD.

Human and Force Factor market competing dietary supplements that incorporate beet root powder. Humann challenged #1 claims in Force Factor’s advertising for its Total Beets® line of beet-based dietary supplements. The challenged claims appear on product packaging, Force Factor’s website, Amazon.com, and in television and social media advertising.

Humann argued that the claims were unsupported, asserting that dollar sales—not unit sales—are the appropriate measure of marketplace leadership and that its brand leads on that basis. Force Factor responded that unit sales are the proper metric because the claims convey that its products are purchased more frequently and submitted current sales data to support its position.

NAD noted that “#1” claims are highly influential and typically communicate that a product is purchased more often than competitors. Consistent with its precedent, NAD determined that unit sales are generally the appropriate metric for substantiating such claims. NAD found that the record did not demonstrate that differences in product form, size, or pricing made unit sales an unreliable measure in this case.

Accordingly, NAD concluded that Force Factor had a reasonable basis for the claims “America’s #1 Best-Selling Beets Brand,” the “#1 Best Selling Beets Brand in America,” and the “#1 Beets Brand in America” with current data on total unit sales.

With respect to the claim “#1 Beets Brand in America,” NAD recommended that Force Factor modify the claim to disclose that the “#1” ranking is based on total unit sales.

In its advertiser statement, Force Factor stated that it “will comply with NAD’s recommendation.”

All BBB National Programs case decision summaries can be found in the case decision library. For the full text of NAD, NARB, and CARU decisions, subscribe to the online archive. Per NAD/NARB Procedures, this release may not be used for promotional purposes.

About BBB National Programs: BBB National Programs, a non-profit organization, is the home of U.S. independent industry self-regulation, currently operating more than 20 globally recognized programs that have been helping enhance consumer trust in business for more than 50 years. These programs provide third-party accountability and dispute resolution services that address existing and emerging industry issues, create fair competition for businesses, and a better experience for consumers. BBB National Programs continues to evolve its work and grow its impact by providing business guidance and fostering best practices in advertising, child-and-teen-directed marketing, data privacy, dispute resolution, automobile warranty, technology, and emerging areas. To learn more, visit bbbprograms.org.

About the National Advertising Division: The National Advertising Division (NAD) of BBB National Programs provides independent self-regulation and dispute resolution services, guiding the truthfulness of advertising across the U.S. NAD reviews national advertising in all media and its decisions set consistent standards for advertising truth and accuracy, delivering meaningful protection to consumers and creating fair competition for business.

New York, NY – July 20, 2026 – In a challenge brought by Beiersdorf, Inc., BBB National Programs’ National Advertising Division determined that, when presented by itself, Vacation, Inc.’s “World’s Best-Smelling Sunscreen” claim is puffery, but in another context recommended the claim be modified.

Fast-Track SWIFT is an expedited process designed for single-issue advertising cases before NAD.

Beiersdorf and Vacation sell competing sunscreen products. Beiersdorf argued Vacation cannot support its “World’s Best-Smelling Sunscreen” claim, while Vacation argued that the claim is puffery. The claim appears on product labels, in retail signage, social media, and Vacation’s website.

Given the subjective nature of the claim and the exaggerated characterization of the product’s smell, NAD found that reasonable consumers are unlikely to view the claim when presented by itself, as objective requiring substantiation. NAD concluded that the claim “World’s Best-Smelling Sunscreen,” when appearing alone on retail signage and the product label, was puffery.

NAD reached a different conclusion with respect to the website claim. The claim appears in quotation marks and is displayed immediately above five stars, with “4.8/5.0” and “13,457 Reviews” immediately below. NAD determined that, in this context, consumers may take away the message that the claim is more than puffery and relies on reviews as substantiation for a claim of preference.

Therefore, NAD recommended that Vacation modify its advertising to avoid conveying the message that the “World’s Best-Smelling Sunscreen” is substantiated by the reviews.

During the proceeding, Vacation voluntarily modified an “award-winning” claim. The modified claim will be treated, for compliance purposes, as if NAD recommended it be modified.

All BBB National Programs case decision summaries can be found in the case decision library. For the full text of NAD, NARB, and CARU decisions, subscribe to the online archive. Per NAD/NARB Procedures, this release may not be used for promotional purposes.

About BBB National Programs: BBB National Programs, a non-profit organization, is the home of U.S. independent industry self-regulation, currently operating more than 20 globally recognized programs that have been helping enhance consumer trust in business for more than 50 years. These programs provide third-party accountability and dispute resolution services that address existing and emerging industry issues, create fair competition for businesses, and a better experience for consumers. BBB National Programs continues to evolve its work and grow its impact by providing business guidance and fostering best practices in advertising, child-and-teen-directed marketing, data privacy, dispute resolution, automobile warranty, technology, and emerging areas. To learn more, visit bbbprograms.org.

About the National Advertising Division: The National Advertising Division (NAD) of BBB National Programs provides independent self-regulation and dispute resolution services, guiding the truthfulness of advertising across the U.S. NAD reviews national advertising in all media and its decisions set consistent standards for advertising truth and accuracy, delivering meaningful protection to consumers and creating fair competition for business.

New York, NY – July 16, 2026 – Following a challenge brought by Elanco Animal Health Incorporated, BBB National Programs’ National Advertising Division determined that PetIQ, LLC provided a reasonable basis for its vet-recommended active-ingredient claims for its PetArmor^® Extend Flea & Tick Collar. However, the National Advertising Division (NAD) recommended that PetIQ modify or discontinue certain claims regarding market leadership, brand growth, consumer trust, comparative performance, and product attributes.

PetIQ and Elanco compete in the market for pet flea-and-tick prevention products. Elanco markets Seresto and PetIQ markets PetArmor Extend, which each contain the active ingredients imidacloprid and flumethrin.

Elanco challenged PetIQ’s brand-superiority and vet-recommended ingredient claims for its PetArmor flea and tick lineup, including assertions that PetArmor Extend is made with the “#1 vet-recommended” active ingredients, alongside claims that PetIQ is the “#1 brand in total solutions” and the “#1 fastest-growing brand” in the category.

NAD determined that PetIQ provided a reasonable basis for its vet-recommended active-ingredient claims, finding that PetIQ’s survey evidence supported the message that veterinarians recommend the imidacloprid and flumethrin active-ingredient combination more than other flea-and-tick collar active-ingredient combinations.

However, NAD determined that PetIQ did not provide adequate support for the broad market-leadership message conveyed by its “#1 Brand in Total Flea & Tick Solutions” claim or the unqualified growth message conveyed by its “#1 Fastest Growing Flea & Tick Brand” claim.

Therefore, NAD recommended that the challenged “#1 Brand” and “#1 Fastest Growing” claims be discontinued or modified to avoid conveying unsupported market leadership and growth messages.

Additionally, NAD recommended that PetIQ discontinue or modify its challenged “trusted by millions,” duration, comparative performance, and product attribute claims to avoid conveying unsupported messages.

In its advertiser statement, PetIQ stated it “agrees to comply with its decision.”

All BBB National Programs case decision summaries can be found in the case decision library. For the full text of NAD, NARB, and CARU decisions, subscribe to the online archive. Per NAD/NARB Procedures, this release may not be used for promotional purposes.

About BBB National Programs: BBB National Programs, a non-profit organization, is the home of U.S. independent industry self-regulation, currently operating more than 20 globally recognized programs that have been helping enhance consumer trust in business for more than 50 years. These programs provide third-party accountability and dispute resolution services that address existing and emerging industry issues, create fair competition for businesses, and a better experience for consumers. BBB National Programs continues to evolve its work and grow its impact by providing business guidance and fostering best practices in advertising, child-and-teen-directed marketing, data privacy, dispute resolution, automobile warranty, technology, and emerging areas. To learn more, visit bbbprograms.org.

About the National Advertising Division: The National Advertising Division (NAD) of BBB National Programs provides independent self-regulation and dispute resolution services, guiding the truthfulness of advertising across the U.S. NAD reviews national advertising in all media and its decisions set consistent standards for advertising truth and accuracy, delivering meaningful protection to consumers and creating fair competition for business.